Related Experiment Videos
Multiple sclerosis associated with duplicated CMT1A: a report of two cases
Journal of Neurology, Neurosurgery, and Psychiatry
|November 5, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Controlling Nonlinear Dynamics of Milling Bodies in Mechanochemical Devices Driven by Pendular Forcing.
Frontiers in chemistry·2022
External Beam Radiotherapy in Western Africa: 1969-2019.
Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Toxicity and inhibition assessment of ionic liquids by activated sludge.
Ecotoxicology and environmental safety·2019
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
Journal of neurology, neurosurgery, and psychiatry·2026
Iatrogenic cerebral amyloid angiopathy: a scoping review.
Journal of neurology, neurosurgery, and psychiatry·2026
Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk.
Journal of neurology, neurosurgery, and psychiatry·2026
Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal).
Journal of neurology, neurosurgery, and psychiatry·2026
HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry·2026
Recombinant factor VIIa for spontaneous intracerebral haemorrhage: a meta-analysis of randomised controlled trials.
Journal of neurology, neurosurgery, and psychiatry·2026
RETRACTION: Up-regulated Mir-192-5p Expression Rescues Cognitive Impairment and Restores Neural Function in Mice With Depression via the Fbln2 -mediated TGF-β1 Signaling Pathway.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Therapeutic Advances and Biomarkers in Multiple Sclerosis.
Current neuropharmacology·2026